The Lumenis™ OptiLIGHT device is FDA-approved for the treatment of dry eye disease due to meibomian gland dysfunction (MGD) for individuals aged 22 and older. IPL (Intense Pulsed Light) is also used to reduce the appearance of red and brown spots on the skin from conditions like rosacea, age spots, and sun spots, and can improve skin texture.
The primary goal of your treatment is to improve the signs and symptoms of dry eye disease, ocular surface disease, and inflammation from MGD. This device has also been used off-label to treat lesions around the eyelid, including chalazion.